Eco-friendly materials are increasingly used in civil engineering to support sustainable development. Conventional concrete relies heavily on Ordinary Portland Cement (OPC), the production of which contributes significantly to the carbon dioxide (CO₂) emissions. Ground Granulated Blast Furnace Slag (GGBFS) and fly ash can partially replace OPC, thereby reducing the environmental impact. This study investigates the effect of basalt fiber incorporation on the mechanical properties of geopolymer lightweight concrete. The concrete mixtures consisted of fly ash, slag, pumice aggregate, sand, and an alkaline activator prepared by combining sodium hydroxide and sodium silicate. The mix design included an activator-to-binder ratio of 0.45, sodium hydroxide molarity of 12 M, and a sodium hydroxide to sodium silicate ratio of 1:2.5. Basalt fiber was added at 0.5%, 0.75%, and 1% by volume. All specimens were cured at 80 ºC for 24 h. The mechanical properties evaluated included compressive strength, splitting tensile strength, and flexural strength. The results showed that basalt fiber significantly improved all measured properties. At 28 days, the compressive strength increased by 11.67%, 14.85%, and 17.5%, the splitting tensile strength by 20%, 27.5%, and 38.75%, and the flexural strength by 21.6%, 32.14%, and 42.73%, respectively.
Copper (Cu) is an essential trace element for the efficient functioning of living organisms. Cu can enter the body in different ways, and when it surpasses the range of biological tolerance, it can have negative consequences. The use of different nanoparticles, especially metal oxide nanoparticles, is increasingly being expanded in the fields of industry and biomedical materials. However, the impact of these nanoparticles on human health is still not completely elucidated. This comparative study was conducted to evaluate the impacts of copper oxide nanoparticles (CuO NPs) and copper sulphate (CuSO4 0.5 (H2O)) on infertility and reproductive function in male albino mice BALB/c. Body weight, the weight of male reproductive organs, mal
... Show MoreThe purpose of this study was to measure serum levels of insulin-like growth factor-binding protein (IGFBP7), Insulin-like Growth Factor 1 (IGF-1), Growth Hormone (GH), Interleukin 6 (IL-6) and insulin in acromegaly patients and healthy controls. The acromegaly group had 60 patients, while the population group had 30 people who had never had acromegaly before. The concentration of IGFBP7, IGF-1, GH, IL-6, and insulin were determined. The results of the present study indicate that IGFBP7 level in the acromegaly group was significantly lower (1.690.07 ng/mL vs. 2.740.12 ng/mL, respectively, p = 0.001). IGF-1, GH, IL-6, and insulin concentrations were also significantly higher in acromegaly patients. The diagnostic accuracy (2.194) was exce
... Show MoreSubstance use disorders are a widely recognized problem among hepatitis C-infected patients; moreover, substance abuse by intravenous injection is a common mode of transmission of the hepatitis C virus worldwide. The frequency of substance use disorders and their relation to hepatitis C infection are still unknown in Iraq. This cross-sectional study, conducted among a sample of hepatitis C- infected patients attending the Gastrointestinal Tract Center in Baghdad Medical City, aimed to examine the prevalence of substance use disorders, the sociodemographic characteristics of the abusers, and the relation between intravenous
Background: Inflammatory bowel disease (IBD) is a collection of chronic, recurrent inflammatory illnesses of the gastrointestinal system, including Crohn's disease (CD). Infliximab is one of the biological medications used to treat CD. Therapeutic drug monitoring has evolved as a treatment in IBD, aiming to optimize benefit while meeting more demanding, objective end criteria. Objective: To determine the achievement of target trough level (TL), develop anti-drug antibodies (ADAs) to infliximab, assess response to therapy, and study TL relations with different variables. Methods: The present study was cross-sectional and conducted from May 2022 to November 2022. It included 40 CD patients allotted into 2 groups: group 1 patients ach
... Show More